Skip to main content

Table 3 Predictors of CIN by multivariate logistic analysis

From: Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study

Variables

OR

95% CI

p value

CoQ10 + TMZ

0.252

0.082–0.774

0.016

Sex

0.761

0.221–2.623

0.665

Age > 65

2.119

0.696–6.457

0.186

LVEF (%)

1.075

0.976–1.185

0.143

BMI

1.046

0.856–1.278

0.661

Diabetes

1.111

0.369–3.348

0.851

Hemoglobin

0.967

0.906–1.032

0.308

Contrast volume ≥ 160 mL

5.570

1.693–18.327

0.005

eGFR ≤ 45 mL/min/1.73 m2

3.010

1.058–8.556

0.039

  1. CIN Contrast-induced nephropathy, eGFR estimated glomerular filtration rate